1 |
Lactobacillus plantarum JLK0142 |
Exopolysaccharides |
EPS also increased IgA concentrations in the intestinal mucosa and stimulated lymphocyte proliferation |
Mice model |
[29] |
2 |
Enterococcus faecium CRL35 |
Peptide |
Inhibited the late stages of HSV-1 and HSV-2 replication |
Vero cells |
[30] |
3 |
Bacillus thuringiensis 6431 |
A two-peptide bacteriocin |
Inhibited the growth of Clostridium difficile
|
Model of the distal colon |
[31] |
4 |
Lactococcus lactis |
Nisin F |
Prevented respiratory tract and subcutaneous skin infections instigated by S. aureus |
Mice model |
[32] |
5 |
Lactobacillus brevis |
Non-protein cell wall component |
Reduced the replication of HSV-2 |
Vero cells |
[33] |
6 |
L. acidophilus, L. rhamnosus and L. casei
|
Peptidoglycans |
Inhibit the release of inflammatory cytokines in models of LPS-induced macrophage-like cells |
HT-29 cells |
[34] |
7 |
L. acidophilus, L. plantarum, L. casei, L. rhamnosus, B. bifidum, S. thermophilus, and S. boulardii
|
Heat killed |
Increase of paracellular permeability, restoration of tight junction function and membrane integrity, and modulating cytokine gene expression |
CacoGoblet cells |
[35] |
8 |
Streptococcus thermophilus CRL1190 |
Exopolysaccharides |
Improve the anti-inflammatory response through the modulation of cytokine IL-8 production |
AGS cells (adherent human gastric adenocarcinoma epithelial cell line) |
[36] |
9 |
Lactobacillus casei and Lactobacillus rhamnosus GG |
Cell-free supernatants (CFS) |
MMP-9 and ZO-1 as targets via which secreted factors from probiotic bacteria Lactobacillus casei and LGG decrease metastasis of colon cancer cells |
Human colon carcinoma cell line HCT-116 |
[37] |
10 |
L. rhamnosus CRL1505 |
Peptidoglycan |
Immunomodulatory properties |
Mice model |
[38] |
11 |
Lactobacillus rhamnosus GG |
Heat inactivated |
Reduction of human rhinovirus infection |
Healthy subjects aged 18 to 65 years |
[39] |
12 |
Lactobacillus sp. RM1 |
Cell-free supernatant |
Antifungal activity influence-inhibited aflatoxin B1 and ochratoxin A production |
MRS broth |
[40] |
13 |
Lactobacillus plantarum RG14 |
Cell-free supernatant |
Enhance ruminal papillae growth, immune status (increase of IL-6 mRNA and decrease of IL-1β, IL-10, TNF mRNA expression), and gastrointestinal health |
Twelve newly weaned male lambs |
[41] |
14 |
Lactobacillus delbrueckii |
Bacteriocin |
Reduces production of viral proteins in infected cells |
Primary chick embryo fibroblasts cell cultures (CEF) |
[42] |
15 |
Bacillus amyloliquefaciens |
Bacteriocin (subtilisin) |
Disrupts late infectious stages of both HSV type 1 |
Vero cell cultures |
[43] |
16 |
Enterococcus faecium |
Enterocin CRL35 |
Found to lower glycoprotein gD synthesis, disrupting a slightly earlier step in the infectious cycle of HSV compared to subtilosin |
Monkey kidney Vero cells |
[44] |
17 |
Lactobacillus plantarum LPL-1 |
Bacteriocins |
Bacteriocins could inhibit the growth of L. monocytogenes by acidifying the cell membrane of L. monocytogenes and creating pores in the bacterial membrane |
Fish |
[45] |
18 |
E. coli Nissle 1917 |
Peptides |
Antimicrobial peptides produced by E. coli Nissle 1917 inhibit the growth of Salmonella enterica by damaging the cell wall structure |
Turkey digestive tract |
[46] |
19 |
Bacillus amyloliquefaciens FPTB16 and Bacillus subtilis FPTB13 |
Heat inactivated |
Immunostimulatory effects |
Catla catla |
[47] |
20 |
Lactobacillus paracasei CBA L74 |
Culture supernatant |
Inhibition of immune cell inflammation and protect the host from pathobionts and enteric pathogens and had protective effects against colitis |
Mice model |
[48] |
21 |
Lactobacillus fermentum and Lactobacillus delbrueckii
|
Heat-killed fermentate |
Increase on sociability and lower baseline corticosterone (stress hormone) levels |
Healthy mice |
[49] |
22 |
Lactobacillus reuteri on the Galleria mellonella
|
Heat killed |
Increase the hemocyte density |
Invertebrate model |
[50] |
23 |
Lactobacillus rhamnosus GG |
Secreted protein |
Treatment of intestinal barrier dysfunction-related diseases |
Rat model |
[51] |
24 |
Lactobacillus casei (Lc) |
Paraprobiotic |
As increased the production of monocyte chemoattractant protein-1 (MCP-1) and T CD4 + CD44 + lymphocytes |
Murine systemic toxoplasmosis model |
[52] |
25 |
L. paracasei CNCM I-1518 |
Peptidoglycans |
Reduced susceptibility to influenza infection, reduced inflammatory cell infiltrates in the lungs, and enhanced the speed of viral clearance |
Influenza infection rodent model |
[53] |
26 |
Butyricicoccus pullicaecorum LMG 24,109 T, Butyricicoccus pullicaecorum 1.20, Faecalibacterium prausnitzii DSM 17,677 |
Butyric acid |
Improve epithelial barrier integrity and management in inflammatory bowel diseases (IBD) and Crohn’s disease (CD) |
Caco-2 model |
[54] |
27 |
Lactobacillus plantarum strain YU |
Heat killed |
Anti-allergic and antiviral effects by activating Th1 immune response and protective immune system |
Mice model |
[55] |
28 |
E. coli Nissle 1917 |
Cell-free soluble factors |
The protective effect against enteropathogenic E. coli induced intestinal epithelial barrier dysfunctioning by triggering the expression of tight junction |
Caco-2 cellular model |
[56] |
29 |
Lactobacillus kefiranofaciens |
Exopolysaccharides |
EPSs such as kefiran are potential candidates for preventing cardiovascular diseases |
Rabbit model |
[57] |
30 |
Lactobacillus rhamnosus GG (LGG) and Lactobacillus gasseri TMC0356 |
Probiotics |
Lactobacilli, such as LGG and TMC0356, might protect a host animal against Flu infection |
Mouse model |
[58] |
31 |
L. plantarum |
SLPs |
Increasing their transepithelial resistance (TER) and down-regulating their permeability |
Caco-2 cells |
[59] |
32 |
Lactobacillus plantarum (Lp.LTA) |
Lipoteichoic acid |
Anti-inflammatory responses |
IPEC-J2 cell line |
[60] |
33 |
Lactobacillus rhamnosus GG |
p40 and p75 |
p40 and p75 induce a significant reduction in the H2O2-induced redistribution of occludin and ZO-1 from the intercellular junctions |
Caco-2, T84, and HT29 cell |
[61] |
34 |
S. epidermidis |
LTA |
LTA-induced antiviral activity is primarily due to the induction of cathelicidin |
Mouse model |
[62] |
35 |
L. johnsonii L531 |
SCFAs |
Alternative for controlling Salmonella infection and maintaining metabolic homeostasis |
Piglets |
[63] |
36 |
L. rhamnosus GG |
Pili |
Promoting strong adhesive interactions with IECs, have a functional role in balancing IL-8 mRNA expression induced by surface molecules such as lipoteichoic acid |
Caco-2 cells |
[64] |
37 |
Lactobacillus plantarum LBP-K10 |
Cyclic dipeptide |
Antiviral activity against influenza A (H3N2) |
Madin-Darby canine kidney cells |
[65] |
38 |
Lactobacillus pentosus strain b240 |
Heat killed |
Increase salivary IgA secretion in humans and prevent IFV infection |
BALB/c mice |
[66] |
39 |
L. acidophilus NCFM |
Aggregation-promoting factors (Apf) |
Apf potentially confers properties that promote bile tolerance and interaction with the host epithelium and, hence, may contribute to the fitness and adaptation of L. acidophilus in the small-intestinal ecosystem |
Caco-2 (ATCC HTB-37) epithelial cell |
[67] |
40 |
Lactobacillus gasseri CP2305 |
Heat inactivated |
Decrease stress induce and increase in salivary cortisol level, increase in expression of stress-responsive microRNAs |
Healthy students (21 males and 11 females) |
[68] |
41 |
L. reuteri |
ROS |
Improves metabolic homeostasis and corrects stress-induced despair behaviors. ROS production in the gut could be used to treat psychiatric disorders |
Mice model |
[69] |
42 |
Lactobacillus reuteri NK33 and Bifidobacterium adolescentis NK98 |
LPS |
NK33 and NK98 additively or synergistically prevented and alleviated anxiety and depression by alleviating gut dysbiosis through the suppression of the proteobacteria population and gut microbiota LPS production |
Mice model |
[70] |
43 |
Lactobacillus plantarum PS128 |
Heat killed |
PS128 has the potential to serve as an anxiolytic agent to regulate the motor functions and the mood of the host, and the chronic PS128 ingestion causes an increase in locomotor behavior and a reduction in anxiety-like behaviors |
Mice Model |
[71] |
44 |
Lactobacillus paracasei PS23 |
Heat killed or live |
Heat-killed PS23 reverses corticosterone-reduced dopamine levels. PS23 improves corticosterone-reduced hippocampal protein levels of MR, GR, and BDNF |
Mouse model |
[72] |
45 |
L. paracasei MTCC1849 |
Heat killed |
L. paracasei MCC1849 has the potential to improve resistance to common cold infections and maintain a desirable mood state, even under mental stress conditions |
Healthy female under exam stress |
[73] |
46 |
Lactobacillus acidophilus DDS-1 |
SCFAs |
L. acidophilus DDS-1 supplementation could be an important dietary strategy to counteract aging-associated dysbiosis |
Mice model |
[74] |
47 |
L. acidophilus and L. casei
|
Cell-free supernatants |
Downregulate the TNF-α secretion and upregulate the anti-inflammatory IL-10 production. L. casei metabolites prevent IL-1β activation induced by LPS |
HT-29 human mucus secreting adenocarcinoma cell line (ATCC HTB-38) |
[75] |
48 |
Lactobacillus plantarum |
Mucus-binding protein (Mub) |
Mub plays an important role in the host-microbial cross talk and possesses the potential for pathogen exclusion to a greater extent than mediated by L. plantarum cells |
Caco-2 and HT-29 cell lines |
[76] |
49 |
L. plantarum N14 |
Exopolysaccharides (EPS) |
NPS and APS play unique roles in the immunomodulatory effect of L. plantarum N14. M |
Porcine intestinal cultured cell line |
[77] |
50 |
Lactobacillus kefir |
S-layer proteins |
S-layer proteins from kefir lactobacilli to antagonize biological effects of bacterial toxins |
Vero cells |
[78] |